Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH DISHMAN PHARMA WYETH/
DISHMAN PHARMA
 
P/E (TTM) x 27.7 30.0 92.4% View Chart
P/BV x 11.3 3.3 336.4% View Chart
Dividend Yield % 10.9 0.7 1,635.4%  

Financials

 WYETH   DISHMAN PHARMA
EQUITY SHARE DATA
    WYETH
Mar-14
DISHMAN PHARMA
Mar-16
WYETH/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,065374 284.5%   
Low Rs553129 429.1%   
Sales per share (Unadj.) Rs289.5197.0 147.0%  
Earnings per share (Unadj.) Rs38.721.2 182.6%  
Cash flow per share (Unadj.) Rs39.934.7 115.0%  
Dividends per share (Unadj.) Rs145.002.00 7,250.0%  
Avg Dividend yield %17.90.8 2,255.1%  
Book value per share (Unadj.) Rs118.5179.9 65.9%  
Shares outstanding (eoy) m22.7280.70 28.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.3 218.8%   
Avg P/E ratio x20.911.9 176.0%  
P/CF ratio (eoy) x20.37.3 279.6%  
Price / Book Value ratio x6.81.4 487.9%  
Dividend payout %374.79.4 3,970.1%   
Avg Mkt Cap Rs m18,38120,307 90.5%   
No. of employees `000NANA-   
Total wages/salary Rs m3595,355 6.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,57715,898 41.4%  
Other income Rs m347265 130.9%   
Total revenues Rs m6,92516,163 42.8%   
Gross profit Rs m1,0234,103 24.9%  
Depreciation Rs m271,091 2.5%   
Interest Rs m4944 0.5%   
Profit before tax Rs m1,3392,334 57.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460624 73.7%   
Profit after tax Rs m8791,710 51.4%  
Gross profit margin %15.625.8 60.3%  
Effective tax rate %34.326.7 128.5%   
Net profit margin %13.410.8 124.3%  
BALANCE SHEET DATA
Current assets Rs m3,96411,018 36.0%   
Current liabilities Rs m2,0819,517 21.9%   
Net working cap to sales %28.69.4 303.2%  
Current ratio x1.91.2 164.5%  
Inventory Days Days3557 61.6%  
Debtors Days Days2783 7,937.4%  
Net fixed assets Rs m87818,787 4.7%   
Share capital Rs m227161 140.8%   
"Free" reserves Rs m2,46614,354 17.2%   
Net worth Rs m2,69314,516 18.6%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m4,84229,805 16.2%  
Interest coverage x306.03.5 8,815.1%   
Debt to equity ratio x00.3 3.2%  
Sales to assets ratio x1.40.5 254.7%   
Return on assets %18.28.9 204.9%  
Return on equity %32.611.8 277.1%  
Return on capital %49.417.5 282.0%  
Exports to sales %0.124.9 0.5%   
Imports to sales %34.73.7 927.7%   
Exports (fob) Rs m83,956 0.2%   
Imports (cif) Rs m2,281594 383.8%   
Fx inflow Rs m84,952 0.2%   
Fx outflow Rs m2,298697 329.9%   
Net fx Rs m-2,2914,255 -53.8%   
CASH FLOW
From Operations Rs m1,1882,786 42.6%  
From Investments Rs m287-1,529 -18.8%  
From Financial Activity Rs m-4,296-941 456.5%  
Net Cashflow Rs m-2,821317 -891.2%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 18.4 23.0 80.1%  
FIIs % 0.0 12.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.9 38.6 126.6%  
Shareholders   25,706 52,291 49.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on WYETH vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

WYETH vs Dishman Pharma Share Price Performance

Period WYETH Dishman Pharma S&P BSE HEALTHCARE
1-Day -2.27% 2.87% 1.18%
1-Month 18.58% -2.45% -0.75%
1-Year 69.59% 96.38% 61.82%
3-Year CAGR 15.36% 89.34% 18.16%
5-Year CAGR 8.95% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the WYETH share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of WYETH hold a 51.1% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WYETH and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, WYETH paid a dividend of Rs 145.0 per share. This amounted to a Dividend Payout ratio of 374.7%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of WYETH, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.